Pomalidomide 4'-PEG4-acidnew

CAS : 2138440-81-8

Ref. 3D-NKD44081

Informations sur le produit

• Nom: Pomalidomide 4'-PEG4-acidnew

Description

Pomalidomide 4'-PEG4-acidnew is a compound that utilizes a PEG linker for pegylation. This process involves the attachment of polyethylene glycol (PEG) to a molecule, in this case, pomalidomide. The resulting product, pomalidomide PEG, has enhanced properties and benefits due to the PEG modification. Amido PEG and heterobifunctional PEG are used in the synthesis of this compound.

The addition of the acid PEG moiety provides improved solubility and stability to pomalidomide, making it more suitable for various applications. The use of PEG products like pomalidomide 4'-PEG4-acidnew allows for controlled release, increased bioavailability, and reduced immunogenicity.

With its unique pegylation feature, Pomalidomide 4'-PEG4-acidnew offers potential advantages in drug delivery systems and targeted therapies. Its modified structure enhances the

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 521.5 g/mol
• Formule: C₂₄H₃₁N₃O₁₀
• Degré de pureté: Min. 95%